Abstract
Both the American College of Obstetricians and Gynecologists (ACOG) and the American Cancer Society have recommended that surgeons should discuss the potential benefits of the prophylactic removal of the Fallopian tubes for permanent contraception or during surgeries for benign pathologies with every woman at risk for ovarian cancer. With the release of the ACOG Committee on Gynecologic Practice, the time has finally come to extend this information from specialist colleges to the entire medical community.